ArticleBritish journal of cancer2024

Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

Débora Contreras-Toledo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.